These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Full-intensity and reduced-intensity allogeneic stem cell transplantation in AML. Craddock CF Bone Marrow Transplant; 2008 Mar; 41(5):415-23. PubMed ID: 18209726 [TBL] [Abstract][Full Text] [Related]
3. Gemtuzumab ozogamicin as part of reduced-intensity conditioning for allogeneic hematopoietic cell transplantation in patients with relapsed acute myeloid leukemia. Bornhäuser M; Illmer T; Oelschlaegel U; Schetelig J; Ordemann R; Schaich M; Hänel M; Schuler U; Thiede C; Kiani A; Platzbecker U; Ehninger G Clin Cancer Res; 2008 Sep; 14(17):5585-93. PubMed ID: 18765552 [TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group. Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985 [TBL] [Abstract][Full Text] [Related]
5. Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia: Who, When, and How? Loke J; Buka R; Craddock C Front Immunol; 2021; 12():659595. PubMed ID: 34012445 [TBL] [Abstract][Full Text] [Related]
6. Conditioning regimens for allogeneic hematopoietic stem cell transplants in acute myeloid leukemia. Jethava YS; Sica S; Savani B; Socola F; Jagasia M; Mohty M; Nagler A; Bacigalupo A Bone Marrow Transplant; 2017 Nov; 52(11):1504-1511. PubMed ID: 28504666 [TBL] [Abstract][Full Text] [Related]
7. Preliminary results of the safety of immunotherapy with gemtuzumab ozogamicin following reduced intensity allogeneic stem cell transplant in children with CD33+ acute myeloid leukemia. Roman E; Cooney E; Harrison L; Militano O; Wolownik K; Hawks R; Foley S; Satwani P; Unal E; Bhatia M; Bradley B; Del Toro G; George D; Garvin J; van de Ven C; Cairo MS Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7164s-7170s. PubMed ID: 16203817 [TBL] [Abstract][Full Text] [Related]
8. Extramedullary relapse of acute leukemia after allogeneic hematopoietic stem cell transplantation: different characteristics between acute myelogenous leukemia and acute lymphoblastic leukemia. Ge L; Ye F; Mao X; Chen J; Sun A; Zhu X; Qiu H; Jin Z; Miao M; Fu C; Ma X; Chen F; Xue S; Ruan C; Wu D; Tang X Biol Blood Marrow Transplant; 2014 Jul; 20(7):1040-7. PubMed ID: 24704575 [TBL] [Abstract][Full Text] [Related]
9. Harnessing the immune system after allogeneic stem cell transplant in acute myeloid leukemia. Sterling C; Webster J Am J Hematol; 2020 May; 95(5):529-547. PubMed ID: 32022292 [TBL] [Abstract][Full Text] [Related]
10. Reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia. Lekakis L; de Lima M Expert Rev Anticancer Ther; 2008 May; 8(5):785-98. PubMed ID: 18471050 [TBL] [Abstract][Full Text] [Related]
11. Concise review: the role of hematopoietic stem cell transplantation in the treatment of acute myeloid leukemia. Hamilton BK; Copelan EA Stem Cells; 2012 Aug; 30(8):1581-6. PubMed ID: 22653712 [TBL] [Abstract][Full Text] [Related]